Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation
Source abstract
Abstract
Polypropylenimine (PPI) dendrimers have been widely used as effective delivery vehicles for drugs and nucleic acids during the past decade. However, biomedical applications of PPI dendrimers were limited because of their serious cytotoxicity and low drug loading capacity. In the present study, acetylated PPI dendrimers with different degrees of acetylation ranging from 14.2% to 94.3% were synthesized and used to encapsulate drugs, including methotrexate sodium, sodium deoxycholate and doxorubicin. Acetylated PPI dendrimers with a degree of acetylation >80% showed a significantly decreased cytotoxicity (>90% cell viability) on MCF-7 and A549 cells. The drug loading capacity of acetylated PPI dendrimers increased proportionally with the degree of acetylation on the dendrimer surface. In addition, 94.3% acetylated PPI dendrimers exhibited a pH-responsive release profile of anticancer drugs loaded within the nanoparticles. The cytotoxicities of methotrexate sodium and doxorubicin on MCF-7 and A549 cells were significantly reduced when they were complexed with acetylated PPI dendrimers with high degrees of acetylation (>80%), owing to sustained drug release from the dendrimers. The results suggest that surface acetylation can reduce the cytotoxicity and improve the anticancer drug loading capacity of cationic dendrimers, and that acetylated PPI dendrimers are promising vehicles for anticancer drugs in clinical trials.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Poly(propylene imine) dendrimers: large-scale synthesis by hetereogeneously catalyzed hydrogenations10.1002/anie.199313081 ↗
2. The treatment of glioblastoma xenografts by surfactant conjugated dendritic nanoconjugates10.1016/j.biomaterials.2011.04.057 ↗
3. Solubilization of a dendrimer into a microemulsion10.1021/jp108040y ↗
4. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery10.1016/j.jconrel.2009.06.019 ↗
5. Dendrimers: novel polymeric nanoarchitectures for solubility enhancement10.1021/bm050802s ↗
6. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison10.1016/j.nano.2010.10.010 ↗
7. Dendrimer toxicity: let’s meet the challenge10.1016/j.ijpharm.2010.04.027 ↗
8. Dendrimer biocompatibility and toxicity10.1016/j.addr.2005.09.019 ↗
9. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives10.1039/c0cs00097c ↗
10. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers10.1016/j.jconrel.2007.03.019 ↗
11. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations10.1007/s11095-010-0339-8 ↗
12. In vivo toxicity of poly(propyleneimine) dendrimers10.1002/jbm.a.33196 ↗
13. Polyamidoamine (PAMAM) dendrimer versus polypropylenimine (PPI) dendrimer on drug loading, complex structure, release behavior, and biocompatibility
14. Spectroscopic investigations of poly(propyleneimine) dendrimers using the solvatochromic probe phenol blue and comparisons to poly(amidoamine) dendrimers10.1021/ac0155355 ↗
15. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors10.1016/j.biomaterials.2010.09.002 ↗
16. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer10.1088/0957-4484/21/24/245104 ↗
17. PEGylated dendrimers with core functionality for biological applications10.1021/bc700264g ↗
18. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs10.1021/bc0000583 ↗
19. Effect of mass transport in the synthesis of partially acetylated dendrimer: implications for functional ligand–nanoparticle distributions10.1021/ma100663c ↗
20. Host–guest chemistry of dendrimer–drug complexes. 6. Fully acetylated dendrimers as biocompatible drug vehicles using dexamethasone 21-phosphate as a model drug10.1021/jp111044k ↗
21. Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy10.1016/j.biomaterials.2010.12.060 ↗
22. Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency10.1021/mp1001312 ↗
23. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles10.1016/j.biomaterials.2011.01.001 ↗
24. Acetylation of poly(amidoamine) dendrimers10.1021/ma021540e ↗
25. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)–folic acid conjugates10.1021/jm901910j ↗
26. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability10.1021/bc0603889 ↗
27. Interactions and encapsulations vitamins C, B3, and B6 with dendrimer in water10.1002/chem.200902995 ↗
28. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy10.1021/jm0401863 ↗
29. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality10.1021/bm0506142 ↗
30. Targeting and inhibition of cell growth by an engineered dendritic nanodevice10.1021/jm040187v ↗
31. Host–guest chemistry of dendrimer–drug complexes. 3. Competitive binding of multiple drugs by a single dendrimer for combination therapy10.1021/jp907437e ↗
32. High-throughput screening of dendrimer-binding drugs10.1021/ja106128u ↗
33. New insights into the interactions between dendrimers and surfactants by two dimensional NOE NMR spectroscopy10.1021/jp804954j ↗
34. Host–guest chemistry of dendrimer–drug complexes. 4. An in-depth look into the binding/encapsulation of guanosine monophosphate by dendrimers10.1021/jp1007889 ↗
35. Dendrimer-based nanoparticles for cancer therapy10.1182/asheducation-2009.1.708 ↗
36. Biomedical applications of dendrimers: a tutorial10.1039/B901839P ↗
37. Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine10.1021/cr900327d ↗
38. PH-dependent encapsulation of pyrene in PPI-core: PAMAM-shell dendrimers10.1021/la8039847 ↗
39. Host–guest chemistry and physico-chemical properties of dendrimer–mycophenolic acid complexes10.1021/jp8078919 ↗
40. Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization10.1021/bc8002343 ↗
41. A measure of endosomal pH by flow cytometry in Dictyostelium10.1186/1756-0500-2-7 ↗